BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 18383234)

  • 1. Leptin, adiponectin, resistin, and ghrelin--implications for inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Kouroumalis EA
    Mol Nutr Food Res; 2008 Aug; 52(8):855-66. PubMed ID: 18383234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.
    Valentini L; Wirth EK; Schweizer U; Hengstermann S; Schaper L; Koernicke T; Dietz E; Norman K; Buning C; Winklhofer-Roob BM; Lochs H; Ockenga J
    Nutrition; 2009 Feb; 25(2):172-81. PubMed ID: 18849144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistin: another rising biomarker in inflammatory bowel disease?
    Karmiris K; Koutroubakis IE
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1035-7. PubMed ID: 17998823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):789-94. PubMed ID: 17700265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipokines as emerging mediators of immune response and inflammation.
    Lago F; Dieguez C; Gómez-Reino J; Gualillo O
    Nat Clin Pract Rheumatol; 2007 Dec; 3(12):716-24. PubMed ID: 18037931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis.
    Toussirot E; Streit G; Nguyen NU; Dumoulin G; Le Huédé G; Saas P; Wendling D
    Metabolism; 2007 Oct; 56(10):1383-9. PubMed ID: 17884449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases.
    Barbier M; Vidal H; Desreumaux P; Dubuquoy L; Bourreille A; Colombel JF; Cherbut C; Galmiche JP
    Gastroenterol Clin Biol; 2003 Nov; 27(11):987-91. PubMed ID: 14732844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationships of hormones of adipose tissue and ghrelin to bone metabolism].
    Zofková I
    Vnitr Lek; 2009 Jun; 55(6):560-4. PubMed ID: 19662887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Kouroumalis EA
    Inflamm Bowel Dis; 2005 Sep; 11(9):847-55. PubMed ID: 16116320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
    Tilg H; Moschen AR
    Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol intake modifies leptin, adiponectin and resistin serum levels and their mRNA expressions in adipose tissue of rats.
    Pravdova E; Macho L; Fickova M
    Endocr Regul; 2009 Jul; 43(3):117-25. PubMed ID: 19817506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipokines: implications for female fertility and obesity.
    Mitchell M; Armstrong DT; Robker RL; Norman RJ
    Reproduction; 2005 Nov; 130(5):583-97. PubMed ID: 16264089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity.
    Stofkova A
    Endocr Regul; 2009 Oct; 43(4):157-68. PubMed ID: 19908934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipokines as uremic toxins.
    Teta D
    J Ren Nutr; 2012 Jan; 22(1):81-5. PubMed ID: 22200420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come.
    Koerner A; Kratzsch J; Kiess W
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):525-46. PubMed ID: 16311215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression.
    Dolezalova R; Lacinova Z; Dolinkova M; Kleiblova P; Haluzikova D; Housa D; Papezova H; Haluzik M
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):674-8. PubMed ID: 17953628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression of placental hormones regulating energy balance in small for gestational age neonates.
    Struwe E; Berzl GM; Schild RL; Dötsch J
    Eur J Obstet Gynecol Reprod Biol; 2009 Jan; 142(1):38-42. PubMed ID: 19004538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipokines: the missing link between insulin resistance and obesity.
    Antuna-Puente B; Feve B; Fellahi S; Bastard JP
    Diabetes Metab; 2008 Feb; 34(1):2-11. PubMed ID: 18093861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokines in liver diseases.
    Marra F; Bertolani C
    Hepatology; 2009 Sep; 50(3):957-69. PubMed ID: 19585655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.